Esophageal Cancer: Should Gender Be Considered as an Influential Factor for Patient Safety in Drug Treatment?
Fengxia LiuHelin FengSumin GuoYuhan ChenQingyi LiuFeng WuWeikuan GuBao-En ShanPublished in: Journal of oncology (2019)
Gender difference in response to treatment potentially most likely exists in esophageal cancer patients, regardless of age, race, and drugs.